In fact, T-Dxd is not only active in a T-DM1 insensitive, HER2-positive patient-derived xenograft model, but it also retains its activity against several BC models with low levels of HER2 expression, unlike T-DM1 [46]. The gene discussed is ERBB2; the disease is breast cancer.